Evidence map›Paper›PMID 19773530›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2009

Blockade of ethanol-induced potentiation of glycine receptors by a peptide that interferes with Gbetagamma binding.

Leonardo Guzman, Gustavo Moraga-Cid, Ariel Avila, Maximiliano Figueroa, Gonzalo E Yevenes, Jorge Fuentealba, Luis G Aguayo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Altered sedative effects of ethanol in mice with α1 glycine receptor subunits that are insensitive to Gβγ modulation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The TM2 6' position of GABA(A) receptors mediates alcohol inhibition.The Journal of pharmacology and experimental therapeutics · 2012
    Article
  17. Activated G protein α s subunits increase the ethanol sensitivity of human glycine receptors.The Journal of pharmacology and experimental therapeutics · 2011
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Leonardo GuzmanLaboratory of Neurophysiology, Department of Physiology, University of Concepción, Concepción, Chile.
Gustavo Moraga-Cid
Ariel Avila
Maximiliano Figueroa
Gonzalo E Yevenes
Jorge Fuentealba
Luis G Aguayo
University of Liège · BEUniversity of Concepción · CL

Funding

Potentiation of Glycine Receptors by EthanolR01AA015150 · NIAAA · UNIVERSITY OF CONCEPCION · PI AGUAYO, LUIS GERARDO · 2004 to 2010
$1.1M
NIAAA NIH HHS AA15150NIAAA NIH HHS R01 AA015150
6 · The paper itself

Abstract

The large intracellular loop (IL) of the glycine receptor (GlyR) interacts with various signaling proteins and plays a fundamental role in trafficking and regulation of several receptor properties, including a direct interaction with Gbetagamma. In the present study, we found that mutation of basic residues in the N-terminal region of the IL reduced the binding of Gbetagamma to 21 +/- 10% of control. Two basic residues in the C-terminal region, on the other hand, contributed to a smaller extent to Gbetagamma binding. Using docking analysis, we found that both basic regions of the IL bind in nearby regions to the Gbetagamma dimer, within an area of high density of amino acids having an electronegative character. Thereafter, we generated a 17-amino acid peptide with the N-terminal sequence of the wild-type IL (RQH) that was able to inhibit the in vitro binding of Gbetagamma to GlyRs to 57 +/- 5% of control in glutathione S-transferase pull-down assays using purified proteins. More interestingly, when the peptide was intracellularly applied to human embryonic kidney 293 cells, it inhibited the Gbetagamma-mediated modulations of G protein-coupled inwardly rectifying potassium channel by baclofen (24 +/- 14% of control) and attenuated the GlyR potentiation by ethanol (51 +/- 10% versus 10 +/- 3%).

Indexed as

Amino Acid SequenceBinding SitesCell LineElectrophysiologyEscherichia coliEthanolGlutathione TransferaseG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHumansModels, MolecularMolecular Sequence DataPeptide FragmentsProtein BindingProtein ConformationEthanolGlutathione TransferaseG-protein Beta gammaG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsPeptide FragmentsProtein SubunitsReceptors, GABA-BReceptors, GlycineRecombinant Fusion Proteins

Identifiers

PMID19773530
PMCPMC2784719
OpenAlexW2107602721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.